Clinical Trial Update: Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581 [Phase 1]

View source ↗

Summary

A Phase 1 single-ascending-dose study with a food-effect cohort evaluated AMG 581 in patients with schizophrenia or schizoaffective disorder; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• AMG 581

Snippet

Sponsor: Amgen | Conditions: Schizophrenia or Schizoaffective Disorder | Phase 1 | Status: COMPLETED